Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-12-20

FDA Approved: TERIFLUNOMIDE — Supplemental Application (Biocon Pharma Inc.)

View source ↗

Summary

The FDA approved Biocon Pharma Inc.'s supplemental application for a generic teriflunomide product, authorizing its marketing in the United States under an ANDA…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Teriflunomide (teriflunomide)

Snippet

SUPPL AP for TERIFLUNOMIDE (TERIFLUNOMIDE)